NSCLC Coverage From Every Angle
Advertisement
Advertisement

Active CE Activities

NCCN 2017 Congress Webinar Series™: Lung Cancer - New Strategies to Improve the Accuracy of Lung Cancer Screening
NCCN 2017 Congress Webinar Series™: Lung Cancer - What, When and How of Biomarker Testing In Non-Small Cell Lung Cancer
Oncology Grand Rounds Series: Part 1 — Non-Small Cell Lung Cancer: A satellite symposium held at the 2017 ONS Annual Congress
Outcomes in NSCLC: A Focus on Quality Improvement - Part 2
Outcomes in NSCLC: A Focus on Quality Improvement - Part 1
EXPERT EXCHANGE: Management of Advanced EGFR Mutation-Positive NSCLC: Making Bold Strides Toward True Precision Medicine
Integrating Targeted Strategies in NSCLC
2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Lung Cancer
Checkpoint Inhibitors in First-Line Advanced NSCLC: What Should You Know?
Treatment of EGFR-Mutated NSCLC: Assessing Your Clinical Practice
Case Studies in ALK-Translocated Advanced NSCLC: From Diagnosis to Treatment
ASTRO Issues New Guidelines on Stereotactic Radiation in Early NSCLC
A Patient-centric, Performance Measures-based Approach to NSCLC
Immunotherapy in Advanced NSCLC: Will Combination Therapies Become Standard?
Clinical Challenges and Best Practices in Managing ALK-Positive NSCLC
Optimizing Patient Care in NSCLC: A Targeted Patient-Centered Approach
ASCO Updates Guidelines for Palliative Care
Nuances in Treating NSCLC
Is There a Standard: PD-L1 IHC Staining
New Frontiers in Decision-Making: Immunotherapy in Advanced Nonsquamous NSCLC
New Frontiers in Decision-Making: Immunotherapy in Advanced Squamous Cell NSCLC
New Frontiers in Decision-Making: Adverse Events With Immunotherapy in NSCLC
Integration of Immunotherapies Into the Treatment of Patients With Non–Small Cell Lung Cancer
Lung Cancer series
NCCN Continuing Education in Lung Cancer